About Thebes Pharmaceuticals Private Limited
Data last updated:
Thebes Pharmaceuticals Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 03 April 2003 and has been in existence for over 23 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24231DL2003PTC119735. Its GSTIN is 10AACCT0562H1ZV (Bihar).
The company has an authorised share capital of ₹2 Lakh and a paid-up capital of ₹1.6 Lakh. It is led by directors including Anindita Mukherjee (Whole-Time Director) and Hemant Kumar.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at A – 11 Third Floor, Pandav Nagar, New Delhi, Delhi, India – 110092.
As per the financials filed for FY 2025, the company reported a revenue of ₹30.2 Lakh, a growth of 58% compared to the previous year. For the same year it recorded a net profit of ₹7,770 (net margin 0.3%) and EBITDA of ₹3.78 Lakh (EBITDA margin 12.5%). Revenue has grown at a compounded annual rate (CAGR) of 6% over three years and 1% over five years.
As per MCA filings, the company has open charges of ₹34.1 Lakh on record. Court records list 1 case involving the company, including 1 filed against it.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website thebespharmaceuticals.com.
Company details
Contact details
Thebes Pharmaceuticals Private Limited's registered office is in New Delhi, Delhi. Its website is thebespharmaceuticals.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressA – 11 Third Floor, Pandav Nagar, New Delhi, Delhi, India – 110092
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Thebes Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Thebes Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Thebes Pharmaceuticals Private Limited, buy the company report.
Financials of Thebes Pharmaceuticals Private Limited
FY 2025 filings availableThebes Pharmaceuticals Private Limited reported revenue of ₹30.2 Lakh (up 58% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 1% over five years, including 58% growth in the latest year. EBITDA rose 311% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹3.78 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹7,770 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 12.5% | ||||
| Net Profit Margin | 0.3% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Thebes Pharmaceuticals Private Limited, buy the company report.
Board of directors of Thebes Pharmaceuticals Private Limited
Thebes Pharmaceuticals has 3 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Anindita Mukherjee | Whole-Time Director | 25 Mar 2004 | 22 Years 7 Months | Current |
| Hemant Kumar Also directs: Megha Peripherals Private Limited | Director | 21 Aug 2023 | 3 Years 2 Months | Current |
| Rakesh Kumar Taneja | Director | 03 Apr 2003 | 23 Years 7 Months | Current |
Peer comparison
Thebes Pharmaceuticals Private Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Maxelon Pharmaceuticals Private Limited | ₹30.23 Lakh (FY 2025) | 5.0% | Naini, Uttar Pradesh, India | |||
| Thebes Pharmaceuticals Private Limitedthis company | ₹30.2 Lakh (FY 2025) | ₹7,770 | 0.3% | 58.0% | New Delhi, Delhi, India | |
| Giniva Pharmaceuticals Private Limited | ₹30.19 Lakh (FY 2024) | -30.0% | Ellisbridge, Ahmedabad, Gujarat, India | |||
| Rubra Pharmaceuticals Limited | ₹30.15 Lakh (FY 2025) | -8.0% | Telangana, India | |||
| Mildness Pharmaceuticals Private Limited | ₹30.09 Lakh (FY 2025) | 13.0% | Garhpura, Bihar, India |
To see the full peer comparison of Thebes Pharmaceuticals Private Limited, buy the company report.
Auditor
Thebes Pharmaceuticals Private Limited is audited by B OJHA & CO for the financial year 2020.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| B OJHA & CO | FY 2020 | 500076N |
Shareholding
The shareholding of Thebes Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2020, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2020 | FY 2019 | FY 2017 | FY 2016 | FY 2015 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Thebes Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 04 Sep 2025 | 101154314 | Others | ₹34.1 Lakh | Open |
Total charge records: 1 View all charges
Legal cases
Thebes Pharmaceuticals Private Limited has 1 court case on record: 1 filed against it. All case is disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 1 | 1 | 0 |
Cases on record (1 of 1)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Gautam Buddha Nagar, Uttar Pradesh | Criminal case | Filed against the company by State Government | Disposed |
To see the full case history of Thebes Pharmaceuticals Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Thebes Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Thebes Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 10AACCT0562H1ZV | Bihar | Active | 18 Sep 2019 |
To see the full GST registrations and return filing status of Thebes Pharmaceuticals Private Limited, buy the company report.
Recent activity
Thebes Pharmaceuticals Private Limited has 5 board changes on record since 2003: 3 appointments and 2 cessations. The latest: Hemant Kumar was appointed as Director on 21 Aug 2023.
Frequently asked questions
Thebes Pharmaceuticals is an active private limited company based in New Delhi, Delhi, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 03 April 2003 (23+ years old) and is registered under CIN U24231DL2003PTC119735.
Thebes Pharmaceuticals has 3 current directors:
- Anindita Mukherjee - Whole-Time Director
- Hemant Kumar - Director
- Rakesh Kumar Taneja - Director
The latest financial statements of Thebes Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Thebes Pharmaceuticals is 10AACCT0562H1ZV, registered in Bihar.
The CIN (Corporate Identification Number) of Thebes Pharmaceuticals is U24231DL2003PTC119735. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Thebes Pharmaceuticals has 1 court case on record: 1 filed against it.
Thebes Pharmaceuticals was incorporated on 03 April 2003, making it 23+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Thebes Pharmaceuticals by revenue are Maxelon Pharmaceuticals Private Limited, Giniva Pharmaceuticals Private Limited, Rubra Pharmaceuticals Limited, Mildness Pharmaceuticals Private Limited, all in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (wholesale trading).
Hemant Kumar was appointed as Director on 21 Aug 2023. Supriyo Mukherjee ceased to be Director on 20 Mar 2018. Nikhilananda Mukherjee ceased to be Director on 25 Dec 2016. Thebes Pharmaceuticals has 5 board changes on record in total.
Thebes Pharmaceuticals can be reached through the website thebespharmaceuticals.com. Its registered office is in New Delhi, Delhi, India.
The registered office of Thebes Pharmaceuticals is at A – 11 Third Floor, Pandav Nagar, New Delhi, Delhi, India – 110092.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
